Sign in

CIK 0001176309

  • Non-accelerated filer
  • Smaller reporting company

ORAMED PHARMACEUTICALS INC.

Sign in to watch
Ticker
ORMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980376008
Phone
+1 646-844-1164
Business address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
Former names
Integrated Security Technologies, Inc., IGUANA VENTURES LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$225,530
in 2 filings, $226K under 10b5-1 plans

Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-01-04 Silberman David Chief Financial Officer Grant or award +136,500 366,500
2023-05-26 Silberman David Chief Financial Officer Grant or award +24,500 230,000
2023-04-17 Silberman David Chief Financial Officer Grant or award +97,500 205,500
2022-07-28 Silberman David Chief Financial Officer Grant or award +39,000 108,000
2022-01-03 Silberman David Chief Financial Officer Grant or award +19,000 69,000
2022-01-03 Silberman David Chief Financial Officer Grant or award · Stock Option (right to buy) +32,000 32,000
2021-09-01 Silberman David Chief Financial Officer Grant or award +50,000 50,000
2021-09-01 Silberman David Chief Financial Officer Grant or award · Stock Option (right to buy) +50,000 50,000

Page 1 of 1 · 8 trades